Ticker Symbol: SPRO
Spero Therapeutics Inc
$16.47 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001701108
Company Profile
Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 675 Massachusetts Ave Ste 14
Website: sperotherapeutics.com
CEO: Ankit Mahadevia
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.17
Change:
-$0.02
(
-1.68%)
Days Range: $1.15 - $1.19
Beta: 0.82
52wk. High: $2.15
52wk. Low: $1.06
Ytd. Change -32.89%
50 Day Moving Average: $1.21
200 Day Moving Average: $1.50
Shares Outstanding: 52716289
Valuation
Market Cap: 6.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A